A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function
PHASE1CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
September 30, 2013
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Conditions
PK of FG-4592Hepatic InsufficiencyHealthy Subjects